Relation of retinol binding protein4, visfatin and vitamin a in obese and non obese Iraqi patients with non alcoholic fatty liver disease
Keywords:
Non alcoholic, fatty liver disease, RBP4, visfatin, body max indexAbstract
One of the most common public liver diseases over the world is fatty liver which contain alcoholic and non-alcoholic fatty liver. One-fourth among general population are impact Non-Alcoholic Fatty Liver Disease (NAFLD) in the worldwide.Retinol binding protein 4 (RBP4) is known as an adipokine, mainly synthesized and secreted from the liver and form adipose tissues. RBP4 acts as a transporter and specifically bound to retinol from liver to others tissues. Visfatin is an adipocytokine and mainly produced from visceral fat tissue, skeletal muscles as well as liver. Vitamin A absorbed, transported as retinyl esters to the liver then hydrolyzed to the retinol form and storage in hepatic stellate cells (HSCs) after reesterified with riglycerides. Hepatic retinyl esters are hydrolyzed to retinol and binds to its carrier RBP4 then transport to the target tissues. Methods: Ninety serum blood samples were collected and distributed into three groups: First group (G1) contained of (34) patients of obese NAFLD. Second group (G2) contained of (26) non obese NAFLD and control patients (G3) contained of (30) patients. Ultrasound was used to confirm the diagnosis of nonalcoholic fatty liver disease by examining the abdomen.
Downloads
References
A.F. AL-Taie, Warka’a T. Saloum; and Forat Yahya Mohsin Shabil. Correlation Study of Retinol Binding Protein (-4), Nesfatin and Thyroid Hormones in Colorectal Cancer Iraqi Male Patients. Plant Archives. 2020, Vol. 20 No. 1, pp. 2841-2846
Ali Saeed, Robin P. F. Dullaart, Tim C. M. A. Schreuder, Hans Blokzijl; Klaas Nico Faber. Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD). Nutrients. 2018, 10, 29. doi:10.3390/nu10010029
Anna Maria R., Marzena S. Is The Retionl Binding Protein 4 A possible Risk Factor for Cardiovascular Disease in Obesity. Int. J. Sci. 2020, 21,(15),5229.https:///doi.org/10.3390/ijms21155229
Ayşegül Sakin, Suleyman Sahin, Ahmet Behlul, Abdullah Sumnu, Meltem Gursu, Abdullah Sakin, Savas Ozturk. The Association of Visfatin Levels With Metabolic Parameters and Inflammation In Diabetic Nephropathy. East J Med. 2020, 25(2): 218-224.DOI: 10.5505/ejm.2020.27122
Bishnu Jwarchan, Subita Lalchan, Anil Dhakal, Ramesh R Acharya. Comparison of Liver Enzymes and Sonological Grading in Nonalcoholic Fatty Liver. Asian J Medical Sciences. 2020, Vol. 11, Issue 2.
Blaner, W.S.; O’Byrne, S.M.; Wongsiriroj, N.; Kluwe, J.; D’Ambrosio, D.M.; Jiang, H.; Schwabe, R.F.; Hillman, E.M.; Piantedosi, R.;Libien, J. Hepatic stellate cell lipid droplets: A specialized lipid droplet for retinoid storage. Biochim. Biophys. Acta 2009, 1791, 467–473.
Carmen Berasain, Matias A. Avila, Cima, IdiSNA. Vitamin A in Nonalcoholic Fatty Liver Disease: A Key Player in an Offside Position?. Cellular and Molecular Gastroenterology and Hepatology 2021, 11:291–293.
Chalasani N., Younossi Z., Lavine JE., Charlton M., Cui K., Rinella M., Harrison SA., et al The Diagnosis and Management of Nonalcoholic Fatty Liver Disease: Practice Guidance from The American Association for The Study of Liver Diseases. Hepatology. 2018, 67: 328-357.
Chaves, G.V.; Pereira, S.E.; Saboya, C.J.; Spitz, D.; Rodrigues, C.S.; Ramalho, A. Association between Liver Vitamin A Reserves and Severity of Nonalcoholic Fatty Liver Disease in the Class III Obese Following Bariatric Surgery. Obes. Surg. 2014, 24, 219–224. [CrossRef] [PubMed]
Chen X, Shen T, Li Q, Chen X, Li Y, Li D, Chen G, Ling W, Chen YM. Retinol binding Protein-4 levels and non-alcoholic fatty liver disease: a communitybased cross-sectional study. Sci Rep. 2017, 7:45100.
Czuba, L.C.; Wu, X.; Huang, W.; Hollingshead, N.; Roberto, J.B.; Kenerson, H.L.; Yeung, R.S.; Crispe, I.N.; Isoherranen, N. Altered vitamin a metabolism in human liver slices corresponds to fibrogenesis. Clin. Transl. Sci. 2021, 14, 976–989. [CrossRef]
Davut Baltacı, Mert Can Tuncel , Mert Cetinkaya, Muhammet Talha Gunduz, Zemze Ozbey, Ozlem Admis, Ismail Hamdi Kara, Handan Ankarali. Evaluation of Visfatin in Patients with Obesity, Metabolic Syndrome, Insulin Resistance and Impaired Glucose Tolerance; Case-Control Study. Acta Medica Anatolia. 2016, Vol. 4 Issue 2.doi: 10.5505/actamedica.2016.00710
Elizabeth E Powell, Vincent Wai-Sun Wong, Mary Rinella. Non-alcoholic fatty liver disease. Lancet. 202, 397: 2212–24
Eloi Frepat; Maria Guillan-Fresco; Ana Alonso-Perez,; Alberto Jorge-Mora; Vera Francisco; Oreste Gualillo; Rodolfo Gόmez. Visfatin Connection: Present and Future in Osteoarthritis and Osteoporosis. J. Clin. Med. 2019, 8, 1178. DOI:10.3390/jcm8081178
Eri Ozaki, Hirotaka Ochiai, Takako shirasawa, et al. Eating Quickly is Associated with A Low Aspartate Aminotrasferase to Alanine aminotrasferase Ratio in Middle-Age Adults: A Large-Scale Cross-Sectional Survey in Japan. Arch. Pub Health. 2020, 78: 101.
Eunice Xiang-Xuan Tan, Jonathan Wei-Jie Lee, Nur Halisah Jumat, Wah-Kheong Chan, Sombat Treeprasertsuk, George Boon-Bee Goh, Jian-Gao Fan, Myeong Jun Song, Phunchai Charatcharoenwitthaya, Ajay Duseja, Kento Imajo, Atsushi Nakajima, Yosuke Seki, Kazunori Kasama, Satoru Kakizaki, Laurentius A. Lesmana, Kenneth I. Zheng, Ming-Hua Zheng, Calvin J. Koh, Khek-Yu Ho, Khean-Lee Goh, Vincent Wai-Sun Wong and Yock-Young Dan. Non-obese non-alcoholic fatty liver disease (NAFLD) in Asia: an international registry study. Metabolism Clinical and Experimental. 2022, 126: 154911. https://doi.org/10.1016/j.metabol.2021.154911 0026-0495.
George S. Riad, Hany A. Hussein, Ahmed Z. Abdel Ghafar. Study of Serum Vistafin Level in patients with Nonalcoholic Fatty Liver Disease and Its Role in Progression to Nonalcoholic Steatohepatitus. Egyptian Liver J. 2018, 8: 49-54
George S. Riada , Hany A. Husseina and Ahmed Z. Abdel Ghafar, Study of serum visfatin level in patients with nonalcoholic fatty liver disease and its role in progression to nonalcoholic steatohepatitis. 2018 Egyptian Liver J.DIO:10.1097/01.EXL.0000544522.99768.5b
Haaker MW, Vaandrager AB, Helms JB. Retinoids in health and disease: a role for hepatic stellate cells in affecting retinoid levels. Biochim Biophys Acta - Mol Cell Biol Lipids 2020:1865.
Hall P., Cash J. What is The Real Function of The Liver 'Function' Tests? Ulster Med J. 2012, 81, 1: 30-36.
Hayatul Najaa Miptah, Anis Safura Ramli, Mariam Mohamad, Hilwati Hashim and Zahirah Tharek. Non-alcoholic fatty liver disease (NAFLD) and the cardiovascular disease (CVD) risk categories in primary care: is there an association? BMC Family Practice. 2020, 21:238 https://doi.org/10.1186/s12875-020-01306-7
Imad Brema, The relationship between plasma Visfatin/Nampt and type 2 diabetes, obesity, insulin resistance and cardiovascular disease. Endocrinology and Metabolism International J. 2016, 3 (6): 00068.
Isaken VT. Larsen MA, Goll R, Florholmen JR; Paulssen EJ. Hepatic Steatosis, Detected by Hepatorenal Index in Ultrasonography, As A Predictor of Insulin Resistance in Obese Subjects. BMC Obes. 2016, 3:39.
Julia S. Steinhoff, Achim Lass and Michael Schupp. Biological Functions of RBP4 and Its Relevance for Human Diseases. Frontiers in Physiology. March 2021, Volume 12, Article 659977 DOI: 10.3389/fphys.2021.659977
K. Ugur, F. Erman, S. Turkoglu, Y. Aydin, A Aksoy, A. Lale, Z.K. Karagoz, I. Ugur, R.F. Akkoc , M. Yalniz. Asprosin, Visfatin and Subfatin as New Biomarker of Obesity and Metabolic Syndrome. European Review for Medical and Pharmacological Sciences. 2022, 26: 2124-2133.
Laurent Castera, Mireen Friedrich-Rust; Rohit Loomba. Noninvasive Assessment of Liver Disease in Patients with Nonalcoholic Fatty Liver Disease. Gastroenterology 2019;156:1264–1281
Marta Melis, Xiao-Han Tang, Steven E. Trasino; Lorraine J. Gudas. Retinoids in The Pathogenesis and Treatment of Liver Diseases. Nutrients 2022, 14, 1456.https://doi.org/10.3390/nu14071456
Martin-Rodriguez JL, Gonzalez-Cantero J, Gonzalez- Cantero A, Arrebola JP, Gonzalez- Calvin JL. Diagnostic Accuracy of Serum Alanin Aminotransferase as Biomarker for Nonalcoholic Fatty Liver Desaes and Insulin Resistance in Healthy Subjects Using 3T MR Spectroscopy. Medicine (Baltimore). 2017, 96: e6770
Milner KL, van der Poorten D, Xu A, Bugianesi E, Kench JG, Lam KS, Chisholm DJ, George J. Adipocyte fatty acid binding protein levels relate to inflammation and fibrosis in nonalcoholic fatty liver disease. Hepatology. 2009, 49:1926–34.
Mohammed Abdel-Hassiba , Abdelhaleem A. Hassaboa , Hossam Elashmawyb , Mostafa I.S. Mansour. Serum visfatin level in prediabetics and its relation to left ventricular function . The Egyptian Journal of Internal Medicine. 2019, 31:703-714
Noé López-Amador , Cirilo Nolasco-Hipolito , Macario de J. Rojas-Jimeno , Octavio CarvajalZarraba. Liver enzymes in patients diagnosed with non-alcoholic fatty liver disease (NAFLD) in Veracruz: a comparative analysis with the literature. Clin. Invest. (Lond.) 2017, 7(1): 011-016
Saeed, A.; Dullaart, R.P.F.; Schreuder, T.C.M.A.; Blokzijl, H.; Faber, K.N. Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD). Nutrients 2017, 10, 29. [CrossRef]
Schina M, Koskinas J, Tiniakos D, Hadziyannis E, Savvas S, Karamanos B, Manesis E, Archimandritis A. Circulating and liver tissue levels of retinol-binding protein-4 in non-alcoholic fatty liver disease. Hepatol Res. 2009, 39: 972–8.
Seo JA, Kim NH, Park SY, Kim HY, Ryu OH, Lee KW, Lee J, Kim DL, Choi KM,Baik SH, Choi DS, Kim SG. Serum retinol-binding protein 4 levels are elevated in non-alcoholic fatty liver disease. Clin Endocrinol (Oxf). 2008, 68:555–60.
Suh JB, Kim SM, Cho GJ, Choi KM. Serum AFBP levels are elevated in patients with nonalcoholic fatty liver disease. Scand J Gastroenterol. 2014, 49: 979–85.
T. Basu; A. Doeve. Significance of Vitamin A (Retinol) in Ageing. The Open Nutraceuticals Journal, 2011, 4, 65-68
Tan, B.K.; Chen, J.; Lehnert, H.; Kennedy, R.; Randeva, H.S. Raised serum, adipocyte, and adipose tissue retinol-binding protein 4 in overweight women with polycystic ovary syndrome: Effects of gonadal and adrenal steroids. J. Clin. Endocrinol. Metab. 2007, 92, 2764–2772.
Thair L. Jabbar and Ali A. Kasim, Association of Retinol Binding Protein- 4 (RBP4) with Glycemia, Dyslipidemia, Hypertension, and Obesity in Type 2 Diabetic Iraqi Patients. Iraqi J Pharm Sci. 2020, Vol. 29(2). https://doi.org/10.31351/vol29iss2pp263-270.
Trasino, S.E.; Tang, X.-H.; Jessurun, J.; Gudas, L.J. Obesity Leads to Tissue, but not Serum Vitamin A Deficiency. Sci. Rep. 2015, 5,15893. [CrossRef] [PubMed]
Verónica Martín-Domínguez, Rosario González-Casas, JorgeMendoza-Jiménez-Ridruejo, Luisa García-Buey; Ricardo Moreno-Otero. Pathogenesis, Diagnosis and Treatment of Non-Alcoholic Fatty Liver Disease. Rev Esp Enferm Dig (Msdrid). 2013, Vol. 105, No. 7, 409-420.
Vicneswarry Dorairaj, Siti Aishah Sulaiman, Nadiah Abu; Nor Azian Abdul Murad. Nonalcoholic Fatty Liver Disease (NAFLD): Pathogenesis and Noninvasive Diagnosis. Biomedicines. 2022, 10,15.
Xiaoyan Li; Hua Wang. Cell and Bioscience. Multiple organs involved in the pathogenesis of Non-Alcoholic Fatty Liver Disease. 2020, 10:140 http://doi.org/10.1186/s13578-020-00507-y
Xinxia Chang, Hongmei Yan , Hua Bian , Mingfeng Xia , Linshan Zhang , Jian Gao and Xin Gao, Serum retinol binding protein 4 is associated with visceral fat in human with nonalcoholic fatty liver disease without known diabetes: a cross-sectional study. Lipids in Health and Disease. 2015, 14:28
Xuefeng Ma, Shousheng Liu, Jie Zhang, Mengzhen Dong, Yifen Wang, Mengke Wang; Yongning Xin. Proportion of NAFLD Patients with Normal ALT Value in Overall NAFLD Patients: A Systematic Review and Meta-Analysis. BMC Gastroenterology. 2020, 20, 10.
Yinuo Liu, Elke Albercht, Dirk Dannenberger, Harald M. Hammon, Christa Kuehn, Helga Sauerwein, Runjun Yang, Zhihui Zhao; Steffen Maak. Retinol Binding Protein4 Abundance in Plasma and Tissues is Related to Body Fat Deposition in Cattle. Scientific Reports. 2019, 9: 8056 https//doi.org/10.1038/s41598-019-44509-4
Yu Z hang, He He, Yu-Ping Zeng, Li-Dan Yang, Dan Jia, Zhen-Mei An; Wei-Guo Jia. Lipoprotein A Combined with Alanine Aminotransferase and Aspartate Aminotransferase, Contributes to Predicting The Occurrence of NASH: A Cross-Sectional Study. Lipids in Health and Disease. 2020, 19: 134.http://doi.org/10.1186/s12944-020-0130x
Yun Zhao, Jiahui Rao, Tong Qiu, Chunjin Li; Xu Zhou. The Effect of RBP4 on microRNA Expression Profiles in Porcine Granulosa Cells. Animals. 2021, 11, 1391.https://doi.org/10.3390/ani11051391
Yunkoo Kang., Sowon Park, Seung Kim; Hog Koh. Normal Serum Alanine Aminotrasferase and Non-Alcoholic Fatty Liver Disease Among Korean Adolescents: A Cross-Sectional study Using Data from KNHANES 2010-2015. BMC Pediatrics. 2018, 18: 215. https://doi.org/10.1186/s12887-018-1202-z
Zhi-Hui Zhang, Jiang-Feng Ke, Jun-Xi Lu, Yun Liu, Ai-Ping Wang, Lian-Xi Li. Serum Retinol-Binding Protein Levels Are Associated with Nonalcoholic Fatty Liver Disease in Chinese Patients with Type 2 Diabetes Mellitus: A Real-World Study. Diabetes Metab J. 2022, 46:129-139.https://doi.org/10.4093/dmj.2020.0222
Zhong, G.; Kirkwood, J.; Won, K.-J.; Tjota, N.; Jeong, H.-Y.; Isoherranen, N. Characterization of Vitamin A Metabolome in Human Livers with and without Nonalcoholic Fatty Liver Disease. J. Pharmacol. Exp. Ther. 2019, 370, 92–103. [CrossRef] [PubMed]
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
